Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia

Medical and Pediatric Oncology

Volumn 32, Issue 3, 1999, Pages 163-169

  Leahey, Ann M ^a,b   Teunissen, Hendrik ^a   Friedman, Debra L ^a   Moshang, Thomas ^a   Lange, Beverly J ^a   Meadows, Anna T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Bone marrow transplantation; Chemotherapy; Late effects; Pediatric acute myeloid leukemia

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGRAFT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; COMPARATIVE STUDY; DRUG EFFECT; ENDOCRINE FUNCTION; FEMALE; HEART FUNCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PRIORITY JOURNAL;

EID: 0033012190     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-911x(199903)32:3<163::aid-mpo1>3.0.co;2-%23     Document Type: Article

References (35)

1. Liesner RJ, Leiper AD, Hann IM, Chessells JM. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994;12:916-924.
2. Shaw PJ, Bergin ME, Burgess MA, et al. Childhood acute leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation. J Clin Oncol 1994;12:2138-2145.
3. Michel G, Gluckman E, Esperou-Bourdeau H, et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1994;12:1217-1222.
4. Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the nordic bone marrow transplantation group. Blood 1994; 83:2723-2730.
5. Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation - a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997;15:2238-2246.
6. Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988;81:102-110.
7. Cutler AT, Benezra-Obeiter R, Brink SJ. Thyroid function in young children with Down syndrome. AJDC 1986;140:479-483.
8. Hayes A, Batshaw ML. Down syndrome. Pediatr Clin North Am 1993;40:523-535.
9. Krick J. Using the z score as a descriptor of discrete changes in growth. Nutritional Support Services 1986;6:14-21.
10. Tanner JM. Growth at adolescence. Oxford: Blackwell Scientific; 1962.
11. Update on the 1987 Task Force Report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649-658.
12. Franklin RCG, Wyse RKH, Graham TP, et al. Normal values for non-invasive estimation of left ventricular contractile state and afterload in children. Am J Cardiol 1990;65:505-510.
13. Creutzig U, Ritter J, Schellong G. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990;75:1932-1940.
14. Dahl GV, Kalwinsky DK, Mirro J, et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1990;8:295-303.
15. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993;11:1046-1054.
16. Nesbit ME, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol 1994;12:127-135.
17. Wells RJ, Woods WG, Buckley JD, et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. J Clin Oncol 1994;12:2367-2377.
18. Woods WG, Neudorf S, Gold S, et al. Aggressive post-remission chemotherapy is better than autologous bone marrow transplantation and allogeneic BMT is superior to both in children with acute myeloid leukemia. Proc Am Soc Clin Oncol 1996;15:368a.
19. Michel G, Leverger G, Leblanc T, et al. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission: a prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Bone Marrow Transplant 1996; 17:191-196.
20. Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68:1129-1135.
21. Brauner R, Fontoura M, Zucker JM, et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993;68:458-463.
22. Thomas BC, Stanhope R, Plowman PN, Lieper AD. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993;152:888-892.
23. Leiper AD, Stanhope R, Lau T, et al. The effect of total body irradiation and hone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Hematol 1987;67:419-426.
24. Wingard JR, Plotnick LP, Freemer CS, et al. Growth in children after bone marrow transplantation: busulfan plus cylophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992;79:1068-1073.
25. Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 1993;123:59-64.
26. Shankar SM, Bunin NJ, Moshang T. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hem Onc 1996;18:362-366.
27. Giorgiani G, Bozzola M, Locatelli F, et al. Role of busulfan and total body irradiation on the growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995;86:825-831.
28. Roman J. Villaizan CJ, Garcia-Foncillas J, et al. Growth and growth hormone secretion in children with cancer treated with chemotherapy. J Pediatr 1997;131:105-112.
29. Friedlaender GE, Tross RB, Doganis AC, et al. Effects of chemotherapeutic agents on bone. J Bone Joint Surg 1984;66:602-607.
30. Sainsbury CPQ, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from acute leukemia. Arch Dis Child 1985;60:832-836.
31. Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Ped Hem Onc 1986;8: 294-299.
32. Groot-Loonen JJ, Otten BJ, van 't Hof MA, et al. Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:92-97.
33. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-3052.
34. Lipshultz SE, Colan SD, Gelber RD, et al. Late effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-815.
35. Goorin AM, Chauvenet AR, Perez-Atayde AR, et al. Initial congestive heart failure, six to ten years after doxorubicin therapy for childhood cancer. J Pediatr 1990;116:144-147.